Settlement reached with the State of Washington brings to an end Washington State’s flawed pharmacy reimbursement plan; offers hope for the ability of pharmacies to continue to meet patients’ needs in Washington State and across the nation
From industry trade press, to publications serving the broader business community, to media outlets relied on by government decision-makers, important story lines about pharmacy benefit manager reform continue to generate headlines and attention across the nation.
NACDS today praised the bipartisan introduction of the Protect Patient Access to Pharmacies Act (S. 2052) – a bill that would help preserve Medicare beneficiaries’ access to their pharmacy of choice and help stop “pharmaceutical benefit manipulation” that harms patients and pharmacies alike.
Organizations representing pharmacists and pharmacies are applauding the Protect Patient Access to Pharmacies Act (S. 2052) introduced on June 21 in the U.S. Senate.
Action is essential component of PBM reform in the Medicaid program and vital for patients and the pharmacies serving them.
Organizations commend House Committee on Oversight and Accountability for hearing on PBM tactics.
NACDS President and CEO Steven C. Anderson released the following statement today in anticipation of a legislative markup on May 24 by the U.S. House of Representatives Committee on Energy and Commerce:
Implementation of NYRx New York Medicaid pharmacy benefit celebrated.
Study reflects “NACDS 2023” focus on adding value to NACDS members’ innovation of health and wellness in the pharmacy and beyond.
NACDS is lauding legislation introduced by U.S. Senators Peter Welch (D-VT) and Roger Marshall (R-KS) to crack down on tactics by which “pharmaceutical benefit manipulator” middlemen maximize profits at the expense of patients, pharmacies, and others.
